BridgeMD
New treatment option for Smoking Cessation
Official title Quitxt Mobile Text Messaging Cessation Research Study
ClinicalTrials.gov ID: NCT05958667
What this study is testing
- What it's testing
- The health benefits of smoking cessation by age 30 are much greater than cessation later in life, including gaining 10 years of life, compared with those who continue to smoke. The goal of the proposed study is to evaluate the effectiveness of the bilingual and culturally tailored Quitxt mobile cessation intervention.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 29. Healthy volunteers may be eligible.
You may be able to join if
- Latinos
- aged 18-29 years;
- smoking at least one cigarette/day ≥3 days/week;
- interested in quitting;
- willing to provide follow-up data;
You likely can't join if
- are not interested in quitting;
- are unable to provide consent due to a mental, emotional, or physical handicap that keep them from understanding the consent information;
- do not own a cell phone with text and Internet capabilities;
- are unable to respond to text messages and questions or unable to view the study mobile webpages/YouTube videos (i.e., if they are blind, deaf); or
- are planning to move from the study area within the study time span.
See the full eligibility criteria
- Latinos
- aged 18-29 years;
- smoking at least one cigarette/day ≥3 days/week;
- interested in quitting;
- willing to provide follow-up data;
- are not simultaneously participating in a cessation program;
- own a cell phone or smartphone;
- are able to send and receive text messages and access the Internet;
- reside in the study area; and
- able to provide informed consent to participate in the study.
- are not interested in quitting;
- are unable to provide consent due to a mental, emotional, or physical handicap that keep them from understanding the consent information;
- do not own a cell phone with text and Internet capabilities;
- are unable to respond to text messages and questions or unable to view the study mobile webpages/YouTube videos (i.e., if they are blind, deaf); or
- are planning to move from the study area within the study time span.
The study team makes the final eligibility decision.
Where it's taking place
- San Antonio, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 29 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include San Antonio, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.